| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |